“Global Supply Chain Visibility and Security; Business Necessity, Regulatory Imperative”

Axendia Launches Life Sciences Research Study

Yardley, PA (PRWEB) May 27, 2010 -- The globalization of manufacturing and supply of medical products has created unique and demanding challenges for the Life Sciences industry and the U.S. Food and Drug Administration alike. In light of recent adverse events, Industry and regulators are preparing to take significant steps to secure the Global Supply Chain. Axendia, Inc., today announced that it has launched a research study entitled, “Global Supply Chain Visibility and Security; Business Necessity, Regulatory Imperative”.

This research seeks to identify and analyze trends, requirements, and initiatives Life-Science companies are undertaking to gain deeper visibility and controls over Global Supply and Value Chains.

In light of recent adverse events, Industry and Regulators are preparing to take significant steps to secure the Life Science Global Supply Chain.

The study will focus on:
   -Assessing current and desired states of Life Science supply chains
   -Identifying key challenges facing global and outsourced ecosystems
   -Outlining innovative strategies and system to enable and guide this transformation
   -Provide a roadmap to achieve Global Supply Chain Visibility and Security

Axendia researchers will seek insight from industry leaders and regulators on innovative strategies and technologies, enabling supply chain visibility and security, risk mitigate, and increased business success.

This research study is co-sponsored by leading companies active in the Life Sciences sector, including (in alphabetical order): Camstar Systems (www.camstar.com) and IBM (www.ibm.com). These companies are working to increase the understanding of processes and systems that support global visibility and transparency across the Life Sciences value chain.

The results of this study will be presented in a report detailing current and best practices in Global Supply Chain Visibility and Security in Life Sciences. The research report will include tables and charts supporting research findings. Axendia will conduct the study research, analysis and report, and retain full editorial control.

About Axendia, Inc.
Axendia is a leading analyst and strategic advisory firm focused on the Life Sciences and Healthcare markets. We provide trusted advice to industry Executives on Business, Regulatory, and Technology issues. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with strategic vision.

Axendia serves the complete Life Science Ecosystem including Industry Organizations, Technology & Service Providers and the Investment community. Our clients range from startups to Fortune 100 companies. We contribute to our client’s success by providing long-range visibility and helping them navigate the ever-changing landscape in the Life Sciences and Healthcare markets.

For more information, visit www.axendia.com or contact us at info(at)axendia(dot)com , read Axendia’s blog: Life-Science Panorama at http://LSP.axendia.com or follow us on Twitter at http://twitter.com/axendia

See Also:

• Optovue Q1 2010 Revenue Up 57% Over Same Quarter 2009
• Confidela is a Finalist for the 2010 Red Herring 100 Europe Award
• Death and Taxes: How a Tariff on Affiliate Marketers May Kill Trade
• LawLogix Announces the Launch of a New Employer Compliance Blog and Online Community by Renowned I-9 and E-Verify Blogger, John Fay
• VarData Deepens Partnership with BlueArc to Enhance Storage Solutions Offerings to Customers

[Via Legal / Law]

sildenafil citrate 100mg | levitra 10mg | paroxetine et prise de poids